Timothy Sullivan - Chief Financial Officer at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Timothy Sullivan - trading volume in the past year for Apellis Pharmaceuticals, Inc.

Holdings reported by Timothy Sullivan for Apellis Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 84.9K $5.63M $66.30 Dec 31, 2024 Direct Common Stock
Common Stock 129K $3.8M $29.52 Jan 29, 2025 Direct
Common Stock 70.4K $2.08M $29.52 Jan 29, 2025 The Timothy E Sullivan Irrevocable Trust of 2023

Transactions reported by Timothy Sullivan for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.